Vineet Laboratories Intrinsic Value
Vineet Laboratories (VINEETLAB) median intrinsic value is ₹42.11 from 8 valuation models (range ₹11–₹62), vs current price ₹36.78 — +14.5% upside (Trading Below Median Value), margin of safety 12.7%. For current market price and key ratios, visit Vineet Laboratories share price chart.
VINEETLAB Valuation Methods Summary — DCF, Graham Number & P/E
Vineet Laboratories intrinsic value across 8 models vs current price ₹36.78 — upside/downside and value range per method. Check VINEETLAB market capitalization to track the company's total market size over time.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹22.00 | ₹17.60 - ₹26.40 | -40.2% | EPS: ₹1.00, Sector P/E: 22x |
| Book Value Method | asset | ₹48.42 | ₹43.58 - ₹53.26 | +31.6% | Book Value/Share: ₹24.21, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹62.11 | ₹55.90 - ₹68.32 | +68.9% | Revenue/Share: ₹31.05, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹42.11 | ₹37.90 - ₹46.32 | +14.5% | EBITDA: ₹8.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹58.63 | ₹46.90 - ₹70.36 | +59.4% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹11.03 | ₹9.93 - ₹12.13 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹13.08 | ₹11.77 - ₹14.39 | -64.4% | Revenue Growth: -25.5%, Adj P/E: 13.1x |
| Graham Defensive Method | conservative | ₹23.34 | ₹21.01 - ₹25.67 | -36.5% | EPS: ₹1.00, BVPS: ₹24.21 |
VINEETLAB Intrinsic Value vs Market Price — All Valuation Models
Vineet Laboratories fair value range ₹11–₹62 vs current market price ₹36.78 across 8 valuation models. See Vineet Laboratories P/B valuation to compare market price against book value per share.
VINEETLAB Intrinsic Value Analysis — Undervalued or Overvalued?
Vineet Laboratories median intrinsic value ₹42.11, current price ₹36.78 — Trading Below Median Value by 14.5%, margin of safety 12.7%.
What is the intrinsic value of VINEETLAB?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Vineet Laboratories (VINEETLAB) is ₹42.11 (median value). With the current market price of ₹36.78, this represents a +14.5% variance from our estimated fair value.
The valuation range spans from ₹11.03 to ₹62.11, indicating ₹11.03 - ₹62.11.
Is VINEETLAB undervalued or overvalued?
Based on our multi-method analysis, Vineet Laboratories (VINEETLAB) appears to be trading below median value by approximately 14.5%.
VINEETLAB Financial Health — Key Ratios vs Industry Benchmarks
Vineet Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 8.25 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 2.2% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 14.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.47x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
VINEETLAB Cash Flow Quality — Operating & Free Cash Flow
Vineet Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹12 Cr | ₹11 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹-7 Cr | ₹-8 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-10 Cr | ₹-14 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹8 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹28 Cr | ₹24 Cr | Positive Free Cash Flow | 8/10 |